◀ Back to ANG

ANG — PLG

Text-mined interactions from Literome

Brown et al., J Clin Endocrinol Metab 2000 (Hyperaldosteronism) : Although previous work has focused on the effect of angiotensin II (Ang II) on plasminogen activator inhibitor ( PAI-1 ) expression, the present study tests the hypothesis that aldosterone contributes to the regulation of PAI-1 expression
Kim et al., Circ Res 2000 : Ang1 induced the secretion of plasmin and matrix metalloproteinase-2 (MMP-2), which is inhibited by PI 3'-kinase inhibitors
Chae et al., Arterioscler Thromb Vasc Biol 2000 (Disease Models, Animal) : Ang1 or VEGF induced migration and sprouting activity, increased plasmin and matrix metalloproteinase-2 secretion, and decreased tissue inhibitors of metalloproteinase type 2 secretion
Sawathiparnich et al., J Clin Endocrinol Metab 2003 : Aldosterone enhances angiotensin II (Ang II) induced plasminogen activator inhibitor (PAI)-1 expression in vitro
Nakai et al., Biochimie 2013 (MAP Kinase Signaling System) : Therefore, we examined the effect of Ang II on the expression of matrix metalloproteinases ( MMPs ), plasminogen activators (PAs), and their inhibitors [ i.e., tissue inhibitors of metalloproteinases ( TIMPs ) and PA inhibitor-1 (PAI-1) ] using osteoblastic ROS17/2.8 cells
Jimi et al., Biochem Biophys Res Commun 1995 (Neovascularization, Pathologic) : Angiogenin up-regulated both mRNA level and activity of urokinase type plasminogen activator, a key mediator of angiogenesis